← Leaderboards
Howard Bernstein
Sqz Biotechnologies Company, Inc.
$831,551
Attributed
$1,663,102
Total exposure
1
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $919.1K · FY2017–18$1M$750K$500K$250K$0
'17
'18
Funding mix
By agency
NIH$1,663,102 · 1
By mechanism
R44$1,663,102 · 1
Top collaborators
- Scott Mcnabb Loughhead3 shared
Others in their field
Other Emerging Leaders on “Analysis Of Variance”
- Michael P Harms · Washington University$13,645,932
- Kristen Harris · University Of Texas At Austin$4,825,000
- John Andrew Pospisilik · Van Andel Research Institute$4,806,312
- Tim Bernard Bigdeli · Rutgers Biomedical And Health Sciences$3,898,708
- Daniel Matute · Univ Of North Carolina Chapel Hill$2,845,678
- Jonathan Flint · University Of California Los Angeles$2,735,019
Research focus
Analysis Of VarianceAntibodiesAntibody FormationAntigen PresentationAntigen-Presenting CellsAntigensBacteriaBaseBiotechnologyBloodBone MarrowBuffersCancer ModelCancer TypeCd8-Positive T-LymphocytesCell CountCell MembraneCellsCell TherapyClinical DevelopmentCommercializationCommunicable DiseasesConstrictionCytokine
Grant awards (3)
Applications of a robust, vector-free intracellular delivery platform for immune cells$755,544
R44 · FY2018 · GM
Applications of a robust, vector-free intracellular delivery platform for immune cells$163,570
R44 · FY2018 · GM
Applications of a robust, vector-free intracellular delivery platform for immune cells$743,988
R44 · FY2017 · GM